@billheight61
actief 13 uren, 20 minuten geleden
Serogroup B meningococci (MenB) remain a prominent cause of invasive meningococcal disease (IMD). The protein-based multicomponent 4CMenB and the bivalent MenB-FHbp are the only currently available vaccines against MenB-caused IMD. Efficacy studies are not possible, due to the low incidence of IMD. Therefore, the vaccines’ immunogenicity has […] Bekijken
Sorry, er is geen activiteit gevonden. Probeer een ander filter.